US 10046028
Methods and compositions for modulating PD1
granted A61KA61K38/1709A61K40/11
Quick answer
US patent 10046028 (Methods and compositions for modulating PD1) held by Sangamo Therapeutics, Inc. expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Aug 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K38/1709, A61K40/11, A61K40/22, A61K40/416